Patient Registries and Cohort Studies
An increased desire to transition from studies designed to meet a single purpose, to reusable data infrastructures that fulfill multiple purposes, has led to a rise in disease and product registries. The availability of electronic health record (EHR) data, and their potential to greatly reduce costs and increase clinical data granularity, has further increased the popularity of these registries in recent years.
Registries help with understand the natural history of a disease, influence the formation of clinical programs, and aid in real-world safety and effectiveness.
In the early development phase, there is increasing reliance on registries to help understand the natural history of a disease and influence clinical programs. In the post-approval stage, registries are being leveraged to measure real-world safety and effectiveness, as well as to uncover new opportunities not evaluated during clinical trials.